课题基金 / 基金详情

A study on tachykininergic neurotransmission in the primate central nervous system aimed at developing novel drugs against mood disorders

A study on tachykininergic neurotransmission in the primate central nervous system aimed at developing novel drugs against mood disorders
对灵长类动物中枢神经系统速激神经传递的研究,旨在开发对抗情绪障碍的新药
批准号:
16590208
负责人:
SUZUKI Hidenori
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

SUZUKI Hidenori的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Research of tachykinin receptors in the non-human primate brain would be useful for elucidating the role of the tachykinin system in higher functions such as emotion, as well as for developing new drugs against mood disorders. To this end, we performed the following experiments.1. We cloned the genes encoding the NK-1 and NK-3 tachykinin receptors (referred to as rmNK-1 and rmNK-3) from the rhesus monkey brain and examined their pharmacological profiles and regional distributions in the CNS. Ligand binding studies revealed that the affinity of rmNK-1 to substance P (SP) was comparable to that of hNK-1 in cell lines that expressed individual receptors stably. The expression of rmNK-1 was observed in all of the cortical and subcortical regions, including the hippocampus and the amygdala. The putamen contained the most NK-1 mRNA in the brain, with less rmNK-3 mRNA found in the cortex compared to rmNK-1 mRNA. In the monkey hippocampus and amygdala, rmNK-1 mRNA was present at markedly highe … More r concentrations than rmNK-3 mRNA.2. We investigated the applicability of experimental animals, ranging from rodents to primates, to positron emission tomographic (PET) measurements with [^<18>F] fluoroethyl-SPA-RQ, a modification of a recently established radioligand for NK-1 receptors. A pharmacokinetic assay could be performed for a rhesus monkey in an awake condition, which allows the circumvention of influences of anesthesia on SP neurotransmission. Coregistration of PET and magnetic resonance images acquired by small-animal-dedicated devices enabled detailed localization of NK-1 receptors in the gerbil and marmoset brains. The present study also revealed the potentials of SDZ NKT 343 as an antagonist for central NK-1 receptors. In conjunction with additional in vitro and ex vivo autoradiographic observations, our in vivo results have demonstrated a similarity in the binding pattern among the animals examined, justifying cross-species extrapolation of PET findings on the SP-NK-1 pathway. Less
期刊论文(55)
专著(0)
科研奖励(0)
会议论文
AAV1 mediated co-expression on formylglycine-generating enzyme and arylsulfatase A efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy.
AAV1 介导的甲酰甘氨酸生成酶和芳基硫酸酯酶 A 的共表达可有效纠正异染性脑白质营养不良小鼠模型中脑硫脂的储存。
DOI: --
发表时间: 2007
期刊: Mol. Ther. 15
影响因子: --
作者: [Kurai, T.]
通讯作者: T.
DOI: 10.1111/j.1460-9568.2006.05079.x
发表时间: 2006-10-01
期刊: EUROPEAN JOURNAL OF NEUROSCIENCE
影响因子: 3.4
作者: [Kobayashi, Katsunori, Ikeda, Yumiko, Suzuki, Hidenori]
通讯作者: Suzuki, Hidenori
Dopamine selectively potentiates hippocamopal mossy fiber to CA3 synaptic transmission.
多巴胺选择性地增强海马苔藓纤维对 CA3 突触的传递。
DOI: --
发表时间: 2007
期刊: Neuropharmacol. 52
影响因子: --
作者: [Kobayashi, K.]
通讯作者: K.
Effects of mirthful laughter on growth hormone, IGF-1 and substance P in patients with rheumatoid arthritis.
欢笑对类风湿关节炎患者生长激素、IGF-1 和 P 物质的影响。
DOI: --
发表时间: 2005
期刊: Clin.Exp.Rheumatol. 23
影响因子: --
作者: [Ishigami, S.]
通讯作者: S.
14
    Development of novel therapeutics for intractable neuropathic pain based on target protector RNA modulating HCN channel function
    • 批准号:
      20K09232
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2020
    • 负责人:
      SUZUKI Hidenori
    • 依托单位:
    Treatment of chronic pain utilizing GABAergic neuron derived from iPS
    • 批准号:
      17K10932
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2017
    • 负责人:
      SUZUKI Hidenori
    • 依托单位:
    Clarification of mechanisms of aneurysmal growth and rupture by quantification of 3D-domain hemodynamic irregularity
    • 批准号:
      17K10825
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2017
    • 负责人:
      SUZUKI Hidenori
    • 依托单位:
    Development of curative treatment against neuropathic pain through comprehensive functional analysis of human long non-coding RNAs
    • 批准号:
      16H05461
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.07万
    • 财政年份:
      2016
    • 负责人:
      SUZUKI Hidenori
    • 依托单位:
    海外基金